Wed, January 19, 2022

Lawrence Biegelsen Upgraded (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022

Lawrence Biegelsen of Wells Fargo, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022.

Lawrence has made no other calls on TNDM in the last 4 months.



There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 1 agrees with Lawrence's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $140 on, Thursday, November 4th, 2021


This is the rating of the analyst that currently disagrees with Lawrence


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $138 on, Thursday, November 4th, 2021